GlassScriptPhysician profile
Bruce F Levy
NPI 1801999230
$686.87
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.07 · 2020: $85.39 · 2021: $508 · 2022: $21.90.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Welch Allyn | $392.63 | 2021 | |
| Boston Scientific Corporation | $77.48 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $40.57 | 2020-2022 | |
| Medtronic Vascular, INC. | $36.90 | 2019-2020 | |
| Esperion Therapeutics, INC. | $28.28 | 2020 | |
| Abbott Laboratories | $24.93 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.79 | 2021 | |
| Merck Sharp & Dohme LLC | $23.53 | 2021 | |
| Amarin Pharma, INC. | $22.86 | 2021 | |
| Medtronic, INC. | $15.90 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.